Stocktoria
ACRO BIOMEDICAL CO., LTD. ACBM
OTC · stock · Services-Amusement & Recreation Services · website · IPO 2016-06-23
ACRO BIOMEDICAL CO., LTD. financials (annual, from 10-K)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $658,500 | $1.2M | $687,964 | $193,536 | $1.4M | $8.0M | $510,000 |
| Gross profit | — | — | $0 | $140,500 | $259,500 | $159,404 | $12,096 | $135,400 | $833,400 | $51,000 |
| R&D expense | — | $0 | $4.8M | $10.1M | $5.3M | — | — | — | — | — |
| SG&A expense | $154,024 | $37,958 | $3.5M | $5.9M | $2.7M | $289,867 | $434,847 | $576,953 | $317,850 | $53,248 |
| Operating income | -$154,024 | -$37,958 | -$8.8M | -$15.9M | -$7.7M | -$130,463 | -$422,751 | -$441,553 | $515,550 | -$2,248 |
| Interest expense | — | — | $3,206 | $1,706 | $893 | $1,067 | — | — | — | — |
| Income tax | $0 | $0 | $0 | $0 | $0 | -$18,092 | -$53,130 | -$73,071 | $92,227 | $0 |
| Net income | -$101,146 | -$42,297 | -$8.8M | -$15.9M | -$7.7M | -$117,453 | -$371,604 | -$370,747 | $419,660 | -$2,248 |
| EPS (diluted) | $0.00 | $0.00 | $-0.15 | $-0.26 | — | — | — | — | — | — |
| Operating cash flow | -$196,302 | -$36,692 | -$15,446 | -$147,481 | $299,335 | -$199,460 | -$59,709 | $79,692 | -$140,419 | -$463,344 |
| Cash & equivalents | — | — | — | — | — | $18,123 | $911 | $1,472 | $1,148 | $36,810 |
| Inventory | — | — | — | — | $0 | $938,000 | $878,560 | $1.1M | $1.1M | — |
| Total assets | $14,098 | $31,974 | $58,459 | $687,486 | $761,077 | $998,053 | $932,126 | $1.1M | $1.5M | $548,310 |
| Total liabilities | — | $326,946 | $315,473 | $201,116 | $117,370 | $312,185 | $133,887 | $195,792 | $240,675 | $36,979 |
| Shareholders' equity | -$386,964 | -$294,972 | -$257,014 | $486,370 | $643,707 | $685,868 | $798,239 | $873,672 | $1.2M | $511,331 |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | -100.0% | -45.0% | +74.1% | +255.5% | -85.7% | -83.1% | +1471.5% | — |
| Net income growth | — | — | — | — | — | — | — | -188.3% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001622996 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.